CREATIVE EXPERTS
Meet our Team

Andras Fehervary
Managing Partner
Andras is an advocacy, market access and public affairs strategist who until 2023 served as Global Head Public & Government Affairs for Boehringer-Ingelheim. He previously was Senior Advisor to FTI Consulting’s healthcare practice, and senior functional leadership positions with Amgen, Novartis, and Eli Lilly & Co. Andras was a member of the EU Committee of Experts on Rare Diseases (EUCERD) and a founder of Rare Cancers Europe. He holds an MBA from INSEAD, a MALD from the Fletcher School of Law & Diplomacy, and a MA in Security Studies from the IHEID Graduate Institute in Geneva. He has authored publications in health, human rights and services and is a frequent moderator and speaker.

Valentine Assal
Senior Strategy Consultant
Valentine is an independent consultant whose current portfolio of activities include development of go-to-market strategies for companies in the area of psychedelics. Her previous experience includes Life Science and Healthcare Senior Consultant with both IQVIA and Monitor Deloitte. She is a graduate of Imperial College London with a Master of Engineering (Meng), Biomaterials and Tissue Engineering.

Oliver van Zon
Senior Access Strategy Advisor
Oliver is a global market access & pricing executive with a finance background. He spent 20 years with Amgen in a variety of value, access and policy roles. His experience lies in life cycle management, launch access and label expansion strategies, portfolio and pipeline strategy. He is passionate about improving patient access and outcomes via smart access strategies and cross-functional collaboration. Oliver speaks 6 languages proficiently. His initial degree was in philosophy, followed by a MSC in economics and an MBA.

Patrick Hopkinson
External Engagement Consultant Market Access / HEOR
Patrick is a global market access expert with over 25 years experience at Bristol Myers Squibb and GlaxoSmithkline in executive HEOR, access, policy and commercial roles. An industry thought leader and regular conference speaker he is passionate about transforming the life science industry and health care stakeholder relationship by focusing on value and the sustainability of health care. He holds degrees in Pharmacy, Health Economics (MSc) and an MBA.

Michal Konstacky, MD, PhD, MBA
Senior Advisor, Medical Affairs & Clinical Development
Michal Konstacky has over 20 years of global experience in Medical Affairs, Clinical Development, and Drug Launches at Roche, Takeda, AstraZeneca, and others. He has led global teams, driven regulatory approvals (FDA & EMA), and launched therapies across neurosciences, rare diseases, cardiometabolic, immunology, respiratory, and GI. A passionate advocate for translational medicine and AI-driven healthcare solutions, Michal ensures research translates into real-world patient impact.

Emil Tsenov, MBA
Senior Advisor, Strategic Marketing & Advocacy
Emil Tsenov is a marketing strategist and patient advocate with 30+ years of experience across healthcare, media, and consumer industries. As founder of the HCM Patient Foundation, he bridges strategic marketing, policy, and advocacy to drive patient-centric awareness and engagement. Emil has advised pharmaceutical companies on patient engagement strategies and teaches Marketing Strategy and Product Development at universities in Austria and the United States

Christine Bouchet, MD
Senior Advisor, Market Access & HEOR
Christine Bouchet is a healthcare strategist with 20+ years of experience in Market Access, HEOR, and Medical Affairs, including 18 years at Novartis. With an MD and advanced degrees in Clinical Epidemiology, Health Economics, and Computer Science, she specializes in evidence generation, reimbursement strategy, and medical policy shaping. Christine helps optimize product value and access, ensuring innovative therapies reach patients effectively.

Francesco Patalano, MD
Senior Advisor, Patient-Centered Drug Development
Francesco Patalano is a pharmaceutical leader with 30+ years in Clinical Development, Medical Affairs, and Market Access. A pioneer in Patient-Reported Outcomes (PROs) and Patient-Focused Medicines Development (PFMD), he has successfully led drug approvals and public-private initiatives to integrate patient insights into development strategies. Francesco holds a Medical Degree and specialty certifications in Pulmonary Diseases and Immunology and has led R&D and manufacturing organizations in Europe and Canada.
OUR VALUES
Integrity. Innovation. Collaboration.
01
Integrity
We build trust through transparency, honesty, and a steadfast commitment to ethical practices.
02
Innovation
We embrace creativity to develop bold, forward-thinking solutions that redefine healthcare possibilities.
03
Collaboration
We foster meaningful partnerships, uniting diverse perspectives to achieve impactful results.
04
Patient Care
We prioritize the well-being and voices of patients, ensuring their needs guide every decision we make.
Insights Delivered to You
Stay updated with the latest in healthcare innovation, policy insights, and patient-focused strategies. Subscribe to our newsletter and get exclusive updates delivered straight to your inbox.

Creative Partners in Health GmbH
Hohlweg 2
4125 Riehen
phone 0000 / 000 000 00
info@creativepartners.health
www.creativepartners.health